Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04475731
What this trial is testing

Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse

Who this might be right for
Philadelphia-Positive ALLAcute Lymphoblastic Leukemia, in Relapse
Gruppo Italiano Malattie EMatologiche dell'Adulto 67
Large-scale testing (Phase 3)Study completedNCT02730299
What this trial is testing

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

Who this might be right for
Hematological MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)+4 more
Gamida Cell ltd 125
Testing effectiveness (Phase 2)Ended earlyNCT02186821
What this trial is testing

Ceritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE)

Who this might be right for
Tumors With Aberrations in ALK or ROS1
Novartis Pharmaceuticals 47
Early research (Phase 1)Looking for participantsNCT05488548
What this trial is testing

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Castrate Resistant Prostate CancerNUT CarcinomaChronic Myelomonocytic Leukemia+1 more
Epigenetix, Inc. 75
Early research (Phase 1)Ended earlyNCT03530683
What this trial is testing

A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma

Who this might be right for
LymphomaMultiple MyelomaAcute Myeloid Leukemia+1 more
Pfizer 189
Early research (Phase 1)Looking for participantsNCT06758713
What this trial is testing

Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies

Who this might be right for
Multiple MyelomaB-cell LymphomaHematological Malignancy
The Third Affiliated Hospital of Southern Medical University 60
Large-scale testing (Phase 3)UnknownNCT05784870
What this trial is testing

Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors

Who this might be right for
Hematological MalignancyCancer-Related Anemia
Zhongnan Hospital 168
Not applicableStudy completedNCT02321345
What this trial is testing

Pretransplant Evaluation by Supportive Care Team for Patients Undergoing HCT for Hematological Malignancies

Who this might be right for
Malignancies, Hematologic
Medical College of Wisconsin 7
Early research (Phase 1)Looking for participantsNCT06225856
What this trial is testing

An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Advanced Solid TumorHematological Malignancy
Shanghai Yuyao Biotech Co., Ltd. 96
Testing effectiveness (Phase 2)Ended earlyNCT01359254
What this trial is testing

Cord Blood Transplantation for Patients With Cancer

Who this might be right for
Hematological Disease
University of Chicago 1
Not applicableUnknownNCT03687463
What this trial is testing

Modified Post-Transplant Cyclophosphamide Regimen for Children With Juvenile Myelomonocytic Leukemia

Who this might be right for
Hematopoietic System--Cancer
Capital Research Institute of Pediatrics 6
Not applicableLooking for participantsNCT07112287
What this trial is testing

Germline Testing for Predisposition to Myeloid Malignancies

Who this might be right for
Myeloid MalignancyGenetic Predisposition to DiseaseMyeloid Hematological Malignancies
Christopher Reilly 200
Early research (Phase 1)UnknownNCT04854681
What this trial is testing

Phase 1 Trial of the TQB2928 Injection in Patients With Advanced Cancers

Who this might be right for
Advanced Solid Tumors and Hematological Malignancies
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 20
Not applicableStudy completedNCT04471961
What this trial is testing

Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia

Who this might be right for
Pediatric TumorFamilial CancerSolid Tumor, Childhood+1 more
University Hospital, Montpellier 100
Not applicableStudy completedNCT07367997
What this trial is testing

Comparative Effectiveness of Verbal Instruction Versus Simulation Video Education Among Cancer Patients Undergoing Radiation Therapy

Who this might be right for
Cancer (Solid Tumors)Cancer and / or Hematological Malignancy
Jinnah Postgraduate Medical Centre 100
Not applicableUnknownNCT05619861
What this trial is testing

CAR-T Cells in the Treatment of Malignant Hematological Tumors

Who this might be right for
Lymphoma, B-CellLeukemia, B-cellLeukemia, T-Cell+1 more
Hebei Senlang Biotechnology Inc., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00365287
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Who this might be right for
Breast CancerKidney CancerLeukemia+3 more
Masonic Cancer Center, University of Minnesota 148
Early research (Phase 1)WithdrawnNCT02786485
What this trial is testing

Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT

Who this might be right for
LeukemiaMyelodysplastic SyndromesLymphomas+2 more
Bellicum Pharmaceuticals
Early research (Phase 1)Study completedNCT01725555
What this trial is testing

Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors

Who this might be right for
Solid TumorsHematological Malignancies
Axelar AB 13
Not applicableWithdrawnNCT00166647
What this trial is testing

Thiopurine Methyltransferase Polymorphisms Evaluation

Who this might be right for
Cancer
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Next Page